ACLS vs LRCX
ACLS: Axcelis Technologies is a leading provider of innovative ion implantation solutions essential for the manufacturing of complex semiconductor devices. LRCX: Lam Research is a leader in essential wafer fabrication equipment, driving the manufacturing breakthroughs needed for next-generation semiconductor devices in AI, cloud, and mobile.
Side-by-side fundamentals
| Metric | ACLS | LRCX | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $133.48 | $320.59 | |
| Market cap | $4.1B | $401.2B | |
| P/E as of 2026-10-08 | 41.57 | 55.62 | ACLS lower |
| Net margin | +14.3% | +31.3% | LRCX higher |
| Gross margin | +44.9% | +50.5% | LRCX higher |
| Operating margin | +14.2% | +35.3% | LRCX higher |
| ROE | +11.6% | +58.3% | LRCX higher |
| ROA | +8.8% | +30.9% | LRCX higher |
| Debt / equity as of 2026-09-03 | 0.04 | 0.30 | ACLS lower |
| Revenue growth (YoY) as of 2026-09-03 | -11.8% | +26.0% | LRCX higher |
| Revenue CAGR (3y) SEC XBRL | -3.0% | +10.1% | LRCX higher |
| Dividend yield as of 2026-09-03 | n/a | +0.4% | |
| Dividend streak (yrs) SEC XBRL | 0 | 4 | LRCX higher |
| Beta as of 2026-09-03 | 1.84 | 2.14 | |
| 1-year return as of 2026-10-08 close | +58.0% | +124.9% | LRCX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.